Cite
APA Citation
Schiff, M., Furst, D., Fleischmann, R., Macri, M., Joh, T., Edwards, C., & Davis, M. (n.d.). fRI0059 The efficacy and safety of pegylated recombinant methionyl human soluble tumour necrosis factor receptor type i (peg stnf-ri; p55) in a randomised, placebo-controlled, clinical study of patients with rheumatoid arthritis (ra). Annals of the rheumatic diseases, 60, A469–A470. http://access.bl.uk/ark:/81055/vdc_100137787100.0x00005e